National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interferon
One of a group of recombinant therapeutic glycoprotein cytokines with antiviral, anti-proliferative, and immunomodulating activities. Interferons bind to specific cell-surface receptors, leading to the transcription and translation of genes with interferon-specific response elements (ISREs). The resultant proteins mediate many complex effects, ultimately leading to inhibition of viral protein synthesis and cellular growth, alteration of cellular differentiation, interference with oncogene expression, activation of natural killer cells, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity. The production of endogenous interferons is induced in response to foreign agents such as bacteria, viruses and parasites and to tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:rIFN



Previous:recombinant human endostatin, recombinant human growth hormone, recombinant human hyaluronidase, recombinant human interleukin-21, recombinant human stem cell factor
Next:recombinant interferon alfa, recombinant interferon alfa-2b, recombinant interferon alpha-1b, recombinant interferon alpha-2a, recombinant interferon beta

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov